Lack of higher frequency of the chemokine receptor 5-Δ32/Δ32 genotype in hepatitis C

Journal of Clinical Gastroenterology

Volumn 40, Issue 5, 2006, Pages 440-443

  Tommasi, Anna Maria ^a   Fabris, Paolo ^b   Carderi, Isabella ^a   Baragiotta, Anna ^a   Baldo, Vincenzo ^a   Venturi, Carla ^a   Giordani, Maria Teresa ^b   Tositti, Giulia ^b   Floreani, Annarosa ^a,c  

^a UNIVERSITY OF PADOVA   (Italy)

^b SAN BORTOLO HOSPITAL   (Italy)

^c Div Gastroenterologia   (Italy)

Author keywords

Hepatitis C virus; Pegylated interferon; Polymorphism

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CHEMOKINE RECEPTOR; CHEMOKINE RECEPTOR CCR5; GAMMA GLUTAMYLTRANSFERASE; PEGINTERFERON; PEGINTERFERON ALPHA2B; RIBAVIRIN;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BLOOD DONOR; COMPARATIVE STUDY; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE SEVERITY; FEMALE; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; GENE AMPLIFICATION; GENE DELETION; GENE FREQUENCY; GENOTYPE; HEPATITIS C; HEPATITIS C VIRUS; HISTOLOGY; HOMOZYGOSITY; HUMAN; HUMAN TISSUE; LIVER DISEASE; MAJOR CLINICAL STUDY; MALE; MUTATION; POLYMERASE CHAIN REACTION; PRIMARY BILIARY CIRRHOSIS; PRIORITY JOURNAL; RECURRENT DISEASE; VIRUS LOAD; WILD TYPE;

ANTIVIRAL AGENTS; CHI-SQUARE DISTRIBUTION; FEMALE; GENE FREQUENCY; GENOTYPE; HEPATITIS C, CHRONIC; HOMOZYGOTE; HUMANS; INTERFERONS; ITALY; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; RECEPTORS, CCR5; VIRAL LOAD;

EID: 33748263562     PISSN: 01920790     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004836-200605000-00015     Document Type: Article

References (17)

1. Woitas RP, Ahlenstiel G, Iwan A, et al. Frequency of the HIV-protective CC chemokine receptor 5-Δ32/Δ32 genotype is increased in hepatitis C. Gastroenterology. 2002;122:1721-1728.
2. Dragic T, Litwin V, Allaway GP, et al. HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5. Nature. 1996;381:667-673.
3. Promrat K, McDermott DH, Gonzales CM, et al. Associations of chemokine system polymorphisms with clinical outcomes and treatment responses of chronic hepatitis C. Gastroenterology. 2003;124:352-360.
4. Laurence J. Potential roles for chemokine receptor CCR5 in the pathobiology of hepatitis C infection. Gastroenterology. 2002;122:2069-2080.
5. Wasmuth HE, Werth A, Mueller T, et al. CC chemokine receptor 5 Δ32 polymorphism in two independent cohorts of hepatitis C virus infected patients without hemophilia. J Mol Med. 2004;82:64-69.
6. Ishak K, Baptista A, Bianchi L, et al. Histological grading and staging of chronic hepatitis. J. Hepatology. 1995;22:696-699.
7. Huang Y, Paxton WA, Wolinsky SM, et al. The role of a mutant CCR5 allele in HIV-1 transmission and disease progression. Nat Med. 1996;2:1240-1243.
8. Elston RC, Forthofer R. Testing for Hardy-Weinberg equilibrium in small samples. Biometrics. 1977;33:536-542.
9. National Institutes of Health Consensus. Development conference Statement Management of Hepatitis C: June 10-12 2002. Available at: http://www. hivandhepatitis.com/hep_c/news/061102a.html. Accessed September 15, 2005.
10. Mascheretti S, Hinrichsen H, Ross S, et al. Genetic variants in the CCR gene cluster and spontaneous viral elimination in hepatitis C-infected patients. Clin Exp Immunol. 2004;136:328-333.
11. Haydon GH, Neuberger J. PBC: an infectious disease? Gut. 2000;47:586-588.
12. Xu L, Shen Z, Guo L, et al. Does a betaretrovirus infection trigger primary biliary cirrhosis? PNAS. 2003;100:8454-8459.
13. Barcellos LF, Schito AM, Rimmler JB, et al. CC-chemokine receptor 5 polymorphism and age onset in familial multiple sclerosis. Multiple Sclerosis Genetics Group. Immunogenetics. 2000;51:281-288.
14. Baragiotta AM, Floreani A, Jones D, et al. Genetic susceptibility to primary biliary cirrhosis (PBC): analysis of chemokine receptor 5 (CCR5) delta32 deletion. J Hepatol. 2001;34(Suppl 1):208.
15. Ahlenstiel G, Berg T, Woitas RP, et al. Effect of the CCR5-Δ32 mutation on antiviral treatment in chronic hepatitis C. J Hepatol. 2003;39:245-252.
16. Glas J, Torok HP, Simperl C, et al. The Δ32 mutation of the chemokine-receptor 5 gene neither is correlated with chronic hepatitis C nor does it predict response to therapy with interferon-Δ and ribavirin. Clin Immunol. 2003;108;46-50.
17. Editorial. Freely associating. Nat Genet. 1999;22:1-2.